Skip to main content

Articles

Page 40 of 76

  1. The transmembrane glycoprotein podoplanin (PDPN) is upregulated in some tumors and has gained attention as a malignant tumor biomarker. PDPN molecules have platelet aggregation-stimulating domains and, are the...

    Authors: Nobuo Watanabe, Masako Kidokoro, Makiko Tanaka, Shigeaki Inoue, Tomoatsu Tsuji, Hisako Akatuska, Chisa Okada, Yumi Iida, Yoshinori Okada, Yusuke Suzuki, Takehito Sato, Takashi Yahata, Noriaki Hirayama, Yoshihide Nakagawa and Sadaki Inokuchi
    Citation: Cancer Cell International 2020 20:263
  2. Multiple Myeloma (MM) is a hematologic malignant disease whose underlying molecular mechanism has not yet fully understood. Generally, cell adhesion plays an important role in MM progression. In our work, we i...

    Authors: Yue Peng, Dong Wu, Fangmei Li, Peihua Zhang, Yuandong Feng and Aili He
    Citation: Cancer Cell International 2020 20:262
  3. Circular RNA downstream neighbor of SON (circDONSON) has been revealed to promote gastric cancer (GC) growth and invasion, while the role and molecular mechanism underlying circDONSON in GC cisplatin (DDP) res...

    Authors: Yong Liu, Jianzhong Xu, Min Jiang, Lingna Ni and Yang Ling
    Citation: Cancer Cell International 2020 20:261
  4. Recent studies have demonstrated that the kallikrein and kallikrein-related peptidases (KLKs) exhibit aberrant expression in patients with colorectal cancer (CRC) and might be considered as potential prognosti...

    Authors: Qiliang Peng, Yi Shen, Peifeng Zhao, Ming Cheng, Yongyou Wu and Yaqun Zhu
    Citation: Cancer Cell International 2020 20:260
  5. Osteosarcoma (OS) is a common malignant bone tumor originating in the interstitial tissues and occurring mostly in adolescents and young adults. Energy metabolism is a prerequisite for cancer cell growth, prol...

    Authors: Naiqiang Zhu, Jingyi Hou, Guiyun Ma, Shuai Guo, Chengliang Zhao and Bin Chen
    Citation: Cancer Cell International 2020 20:259
  6. Cisplatin is widely used as a first-line treatment for non-small cell lung cancer (NSCLC), but chemoresistance remains a major clinical obstacle for efficient use. As a microRNA, miR-223 was reported to promot...

    Authors: Hui Wang, Jiabin Chen, Shufen Zhang, Xiaoxiao Zheng, Shangzhi Xie, Jiayan Mao, Ying Cai, Xuemei Lu, Liqiang Hu, Jian Shen, Kequn Chai and Wei Chen
    Citation: Cancer Cell International 2020 20:258
  7. Deregulation of integrins signaling had been documented to participate in multiple fundamental biological processes, and the aberrant expression of integrin family members were linked to the prognosis of vario...

    Authors: Tingting Zhu, Ruifang Chen, Jieyu Wang, Huiran Yue, Xin Lu and Jun Li
    Citation: Cancer Cell International 2020 20:257
  8. Fyn has been documented to have oncogenic features in multiple tumors, which might be a potential therapeutic target, however, few studies on the function role of Fyn and its specific inhibitors in melanoma.

    Authors: Ling Tang, Jing Long, Keke Li, Xu Zhang, Xiang Chen and Cong Peng
    Citation: Cancer Cell International 2020 20:256
  9. Bladder cancer (BCA) is the most common urinary tumor, but its pathogenesis is unclear, and the associated treatment strategy has rarely been updated. In recent years, a deeper understanding of tumor epigeneti...

    Authors: Zijian Tian, Lingfeng Meng, Xingbo Long, Tongxiang Diao, Maolin Hu, Miao Wang, Ming Liu and Jianye Wang
    Citation: Cancer Cell International 2020 20:255
  10. MicroRNAs (miRNAs) involved in key signaling pathways and aggressive phenotypes of osteosarcoma (OS) was discussed, including PI3K/AKT/MTOR, MTOR AND RAF-1 signaling, tumor suppressor P53- linked miRNAs, NOTCH...

    Authors: Babak Otoukesh, Mehdi Abbasi, Habib-o-Lah Gorgani, Hossein Farahini, Mehdi Moghtadaei, Bahram Boddouhi, Peyman Kaghazian, Shayan Hosseinzadeh and Atefe Alaee
    Citation: Cancer Cell International 2020 20:254
  11. CDK4/6 inhibitors such as ribociclib are becoming widely used targeted therapies in hormone-receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2−) breast cancer. However, cancers can...

    Authors: Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond, Patrick A. Cosgrove, Lance Pflieger, Aritro Nath, Philip J. Moos and Andrea H. Bild
    Citation: Cancer Cell International 2020 20:253
  12. Increasing evidence has indicated the important role of long non-coding RNAs (lncRNAs) in regulating the development and progression of cancers, including triple-negative breast cancer (TNBC). Small nucleolar ...

    Authors: Xuan Fang, Jin Zhang, Chunyan Li, Jinjin Liu, Zhendong Shi and Peng Zhou
    Citation: Cancer Cell International 2020 20:252
  13. Hepatocellular carcinoma (HCC) one of the most common digestive system tumors, threatens the tens of thousands of people with high morbidity and mortality world widely. The purpose of our study was to investig...

    Authors: Lingyun Guo, Zhenjiang Wang, Yuanyuan Du, Jie Mao, Junqiang Zhang, Zeyuan Yu, Jiwu Guo, Jun Zhao, Huinian Zhou, Haitao Wang, Yanmei Gu and Yumin Li
    Citation: Cancer Cell International 2020 20:251
  14. Acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) have a high relapse rate and poor prognosis. This study aims to explore the underlying mechanism of ...

    Authors: Xiaoli Hu, Jiayi Cai, Jianyi Zhu, Wenjing Lang, Jihua Zhong, Hua Zhong and Fangyuan Chen
    Citation: Cancer Cell International 2020 20:250
  15. Circular RNAs (circRNAs), a subgroup of non-coding RNAs, are recognized as pivotal mediators in various types of cancers. CircRNA_0000284 (circ_0000284) was manifested to participate in the development of non-...

    Authors: Li Li, Qiaohua Zhang and Ke Lian
    Citation: Cancer Cell International 2020 20:247
  16. Matrine has been reported to exert anti-tumor effects in multiple types of cancers containing hepatocellular carcinoma (HCC). However, the anti-tumor molecular mechanisms of matrine in HCC is still not fully r...

    Authors: Shaobing Lin, Jie Zhuang, Liping Zhu and Zongsheng Jiang
    Citation: Cancer Cell International 2020 20:246
  17. Osteosarcoma (OS) is the most common primary bone malignancy in children and adolescents, and hyperproliferation of cells is a major problem of OS. FBXO2 belongs to the family of F-box proteins, and is a subst...

    Authors: Xunming Zhao, Weichun Guo, Lixue Zou and Biao Hu
    Citation: Cancer Cell International 2020 20:245
  18. Vaccinia viruses have emerged as attractive therapeutic candidates for cancer treatment due to their inherent ability of tumor tropism and oncolytic property. Cytosine deaminase (CD), which is derived from bac...

    Authors: Yuedi Ding, Jun Fan, Lili Deng, Biao Huang and Bin Zhou
    Citation: Cancer Cell International 2020 20:243
  19. Emerging studies have demonstrated that circular RNAs (circRNAs) are key regulators for tumorigenesis in cancers, including papillary thyroid carcinoma (PTC). In this study, we aimed to explore the effects of ...

    Authors: Xiaolong Gui, Yan Li, Xiaobin Zhang, Ka Su and Wenlong Cao
    Citation: Cancer Cell International 2020 20:241
  20. Endometrial cancer was the commonest gynecological malignancy in developed countries. Despite striking advances in multimodality management, however, for patients in advanced stage, targeted therapy still rema...

    Authors: Hongyu Zhou, Chufan Zhang, Haoran Li, Lihua Chen and Xi Cheng
    Citation: Cancer Cell International 2020 20:240
  21. The incidence and mortality of melanoma is increasing around the world. To deeply explain the mechanism insight into it, we conducted a systematic analysis to examine the levels of regulatory genes of the comm...

    Authors: Tengda Li, Mingli Gu, Anmei Deng and Cheng Qian
    Citation: Cancer Cell International 2020 20:239
  22. Non-receptor protein tyrosine phosphatases (PTPNs) are a set of enzymes involved in the tyrosyl phosphorylation. The present study intended to clarify the associations between the expression patterns of PTPN f...

    Authors: Jing Chen, Xu Zhao, Yuan Yuan and Jing-Jing Jing
    Citation: Cancer Cell International 2020 20:238
  23. The aberrant expression of microRNA-454 (miR-454) has been confirmed to be involved in the development of cancers. However, the functional role of miR-454 in the progression of ovarian cancer remains unclear.

    Authors: Yunhe An, Jun Zhang, Xiaoyan Cheng, Baoming Li, Yanjie Tian, Xiaoli Zhang and Fangqi Zhao
    Citation: Cancer Cell International 2020 20:237
  24. Long noncoding RNA small nucleolar RNA host gene 16 (lncRNA SNHG16) has been revealed to be involved in the tumorigenesis of neuroblastoma. However, the role of SNHG16 in regulating cisplatin sensitivity in ne...

    Authors: Zhaoying Xu, Yongfa Sun, Danfeng Wang, Huifang Sun and Xiaojun Liu
    Citation: Cancer Cell International 2020 20:236
  25. Aberrant DNA methylation patterns are involved in the pathogenesis of papillary renal cell carcinoma (pRCC). This study aimed to investigate the potential of methylation-driven genes as biomarkers in determini...

    Authors: Zeyu Liu, Yuxiang Wan, Ming Yang, Xuewei Qi, Zhenzhen Dong, Jinchang Huang and Jingnan Xu
    Citation: Cancer Cell International 2020 20:235
  26. Kinesin superfamily proteins (KIFs) serve as microtubule-dependent molecular motors, and are involved in the progression of many malignant tumors. In this study, we aimed to investigate the expression pattern ...

    Authors: Zhi-Gang Sun, Feng Pan, Jing-Bo Shao, Qian-Qian Yan, Lu Lu and Nan Zhang
    Citation: Cancer Cell International 2020 20:233
  27. Dysregulation of long non-coding RNAs (lncRNAs) results in development of human diseases including hepatocellular carcinoma (HCC). Although several HCC related lncRNAs have been reported, the biological functi...

    Authors: Qiang Fei, Feihong Song, Xinwei Jiang, Han Hong, Xiaoyong Xu, Zhengkang Jin, Xiang Zhu, Binghua Dai, Jiamei Yang, Chengjun Sui and Minhui Xu
    Citation: Cancer Cell International 2020 20:232
  28. Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network...

    Authors: Wanqing Weng, Zhongjing Zhang, Weiguo Huang, Xiangxiang Xu, Boda Wu, Tingbo Ye, Yunfeng Shan, Keqing Shi and Zhuo Lin
    Citation: Cancer Cell International 2020 20:231

    The Correction to this article has been published in Cancer Cell International 2020 20:282

  29. We aimed to identify differentially expressed pseudogenes and explore their potential functions in four types of common gynecological malignancies (e.g., cervical squamous cell carcinoma, ovarian serous cystad...

    Authors: Shitong Lin, Yifan Meng, Canhui Cao, Ping Wu, Peipei Gao, Wenhua Zhi, Ting Peng and Peng Wu
    Citation: Cancer Cell International 2020 20:229
  30. Lung adenocarcinoma has surpassed lung squamous cell carcinoma as the most common type of non-small cell lung cancer. In this study, we had tested the biological role of TRIM2 in lung adenocarcinoma.

    Authors: Zhaoxian Lin, Xing Lin, Lihuan Zhu, Jianyuan Huang and Yangyun Huang
    Citation: Cancer Cell International 2020 20:228
  31. MicroRNAs (miRNAs) serve as important regulators of the tumorigenesis and progression of many human cancers. Therefore, we evaluated the biological function and underlying mechanism of miR-363 in clear cell re...

    Authors: Yongpeng Xie, Luyao Chen, Yu Gao, Xin Ma, Weiyang He, Yu Zhang, Fan Zhang, Yang Fan, Liangyou Gu, Pin Li, Xu Zhang and Xin Gou
    Citation: Cancer Cell International 2020 20:227
  32. Hepatocellular carcinoma (HCC) is a common tumor characterized by high morbidity and mortality rates. The importance of circRNA in cancer diagnosis has been established. The study aimed to identify differentia...

    Authors: Xiang-Hong Sun, Yu-Tong Wang, Guo-Fu Li, Nan Zhang and Ling Fan
    Citation: Cancer Cell International 2020 20:226
  33. Pancreatic cancer is a highly malignant gastrointestinal cancer that can widely metastasize during the early stage of disease, and it is associated with one of the worst prognoses among cancers. In this study,...

    Authors: Yongping Zhou, Zhiyuan Hua, Ye Zhu, Liying Wang, Fangming Chen, Ting Shan, Yunhai Zhou and Tu Dai
    Citation: Cancer Cell International 2020 20:225
  34. Osteosarcoma (OS) is a common malignant bone cancer and is still a growing threat to young people. Circular RNAs (CircRNAs) are reported to be involved in the development of diverse human cancers. However, the...

    Authors: Haojie Wu, Weihua Li, Shutao Zhu, Dengfeng Zhang and Minghui Zhang
    Citation: Cancer Cell International 2020 20:223
  35. A novel systemic immune-inflammation index (SII), based on the neutrophils, lymphocytes and platelet counts, is associated with the prognosis of several cancers. The present study evaluates the prognostic sign...

    Authors: Xu Hu, Yan-Xiang Shao, Zhi-Qiang Yang, Wei-Chao Dou, San-Chao Xiong and Xiang Li
    Citation: Cancer Cell International 2020 20:222
  36. Because cell movement is primarily driven by the connection between F-actin and integrin through a physical linkage, cellular elasticity and adhesion strength have been considered as biomarkers of cell motilit...

    Authors: Sangwoo Kwon, Woochul Yang, Donggerami Moon and Kyung Sook Kim
    Citation: Cancer Cell International 2020 20:217
  37. ZKSCAN3, a zinc-finger transcription factor containing KRAB and SCAN domains, has been reported to be regulated in several human cancers. However, its expression and function in hepatocellular carcinoma (HCC) ...

    Authors: Jieqiong Li, Nan Hao, Juan Han, Mi Zhang, Xiaomei Li and Nan Yang
    Citation: Cancer Cell International 2020 20:216
  38. Understanding the molecular mechanism of long non-coding RNAs (lncRNAs) in carcinogenesis is conducive for providing potential target for cancers. The role of FLVCR1-AS1 in breast cancer (BC) has not been prob...

    Authors: Zhiyu Pan, Junbin Ding, Zhen Yang, Huaqing Li, Hongjian Ding and Qian Chen
    Citation: Cancer Cell International 2020 20:214

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here